We are live on ! Find out more
ACM

Accent Capital Management Portfolio holdings

AUM $206M
1-Year Est. Return 29.56%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+29.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$206M
AUM Growth
-$26.4M
Cap. Flow
-$7.39M
Cap. Flow %
-3.58%
Top 10 Hldgs %
69.38%
Holding
412
New
65
Increased
63
Reduced
65
Closed
78

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$95.3K
2
ASML icon
ASML
ASML
+$78.1K
3
AZN icon
AstraZeneca
AZN
+$78.1K
4
VTI icon
Vanguard Total Stock Market ETF
VTI
+$72.8K
5
NVS icon
Novartis
NVS
+$69.6K

Sector Composition

Rank Sector Weight
1 Technology 36.33%
2 Communication Services 18.36%
3 Consumer Discretionary 11.2%
4 Financials 8.78%
5 Consumer Staples 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
201
DELISTED
Alexion Pharmaceuticals
ALXN
$6.82K ﹤0.01%
193
LRN icon
202
Stride
LRN
$3.69B
$6.7K ﹤0.01%
+76
New +$6.16K
OSK icon
203
Oshkosh
OSK
$9.67B
$6.69K ﹤0.01%
583
NRG icon
204
NRG Energy
NRG
$29.8B
$6.58K ﹤0.01%
45
LHX icon
205
L3Harris
LHX
$55.9B
$6.56K ﹤0.01%
19
PLMR icon
206
Palomar
PLMR
$3.65B
$6.45K ﹤0.01%
54
MIRM icon
207
Mirum Pharmaceuticals
MIRM
$6.89B
$6.45K ﹤0.01%
347
JBL icon
208
Jabil
JBL
$32.8B
$6.38K ﹤0.01%
24
ITRI icon
209
Itron
ITRI
$3.73B
$6.36K ﹤0.01%
71
QUAL icon
210
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
$6.33K ﹤0.01%
+33
New +$6.61K
IONQ icon
211
IonQ
IONQ
$12.3B
$6.23K ﹤0.01%
216
-371
-63% -$14.2K
ANRO icon
212
Alto Neuroscience
ANRO
$1.04B
$6.18K ﹤0.01%
+275
New +$5.1K
HAL icon
213
Halliburton
HAL
$27.9B
$6.16K ﹤0.01%
+158
New +$5.47K
SE icon
214
Sea Limited
SE
$61.2B
$6.13K ﹤0.01%
74
BNY
215
Bank of New York Mellon
BNY
$108B
$6.05K ﹤0.01%
51
PWR icon
216
Quanta Services
PWR
$93.9B
$6.04K ﹤0.01%
11
-2
-15% -$1.03K
EAT icon
217
Brinker International
EAT
$8.02B
$6K ﹤0.01%
42
STT icon
218
State Street
STT
$50.9B
$5.95K ﹤0.01%
47
EME icon
219
Emcor
EME
$33.1B
$5.91K ﹤0.01%
8
WLDN icon
220
Willdan Group
WLDN
$1.1B
$5.82K ﹤0.01%
+76
New +$8.04K
APLD icon
221
Applied Digital
APLD
$7.77B
$5.82K ﹤0.01%
+245
New +$7.67K
FIVE icon
222
Five Below
FIVE
$11.2B
$5.71K ﹤0.01%
+25
New +$5.23K
ROST icon
223
Ross Stores
ROST
$76.6B
$5.63K ﹤0.01%
26
-41
-61% -$8.17K
KTOS icon
224
Kratos Defense & Security Solutions
KTOS
$8.88B
$5.57K ﹤0.01%
+79
New +$7.58K
TGTX icon
225
TG Therapeutics
TGTX
$8.58B
$5.45K ﹤0.01%
164

Similar funds

Accent Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Accent Capital Management held 412 positions worth $206M, down 11% from $233M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Accent Capital Management withdrew a net $7.39M in Q1 2026, closing 78 positions and reducing 65 holdings. Its most notable exit was UnitedHealth, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Accent Capital Management opened a new position in Novartis worth $69.3K.

  • Accent Capital Management's largest Q1 2026 buy was Novartis: 454 shares worth $69.3K.
  • Accent Capital Management added most to TSMC in Q1 2026, an estimated $95.3K increase.
  • Accent Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $1.37M.
  • Accent Capital Management fully exited UnitedHealth in Q1 2026, selling an estimated $2.17M.
  • Accent Capital Management's ten largest holdings make up 69% of its $206M portfolio in Q1 2026.
  • Accent Capital Management opened 65 new positions and closed 78 in Q1 2026.
  • Accent Capital Management's portfolio value fell 11% quarter-over-quarter to $206M.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.